Cerebral foreign body reaction due to hydrophilic polymer embolization following aneurysm treatment by pipeline flow diversion device

被引:10
|
作者
Geisbush, Thomas Rand [1 ]
Marks, Michael P. [2 ]
Heit, Jeremy J. [2 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Chicago, IL USA
[2] Stanford Hosp & Clin, 300 Pasteur Dr,Room S-047, Stanford, CA 94305 USA
关键词
Granulomatous inflammation; foreign body reaction; hydrophilic polymer embolization; flow diverting stent; cerebral aneurysm; ENDOVASCULAR TREATMENT; COMPLICATIONS;
D O I
10.1177/1591019919830767
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The use of flow diverting stents for wide based, intracranial aneurysms has become an invaluable treatment option. While intracranial hemorrhage and ischemic stroke from dislodged atherosclerotic emboli are common adverse events, the potential for delayed granulomatous inflammation from possible hydrophilic polymer emboli is rarely recognized. We present a unique case in which visible chipping of the pusher wire for stent placement was observed, followed by clinical and radiographic evidence suggestive of a delayed foreign body reaction to intracranial hydrophilic polymer emboli. A 55-year-old woman underwent placement of a Pipeline embolization device for a left-sided, broad-based aneurysm at the base of the internal carotid artery and posterior communicating artery. Two months later she developed right-sided focal neurological deficits. Imaging showed ipsilateral focal edema and enhancing lesions with contrast. Although not confirmed with biopsy and histopathology, clinical and radiographic evidence suggests that this patient probably experienced a delayed foreign body reaction to hydrophilic polymer emboli from compromised procedural equipment during flow diverting stent placement. Although previously described, this is the first instance to our knowledge in whichvisible chipping of the pusher wire was observed on a Pipeline embolization device.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 43 条
  • [41] Diffusion weighted image documented cerebral ischemia in the postprocedural period following pipeline embolization device with shield technology treatment of unruptured intracranial aneurysms: a prospective, single center study
    Pikis, Stylianos
    Mantziaris, Georgios
    Mamalis, Vasileios
    Barkas, Konstantinos
    Tsanis, Antonios
    Lyra, Stavroula
    Karkoulias, Kuriakos
    Petrosyan, Tigran
    Archontakis, Eftychios
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2020, 12 (04) : 407 - +
  • [42] Safety, efficacy, and short-term follow-up of the use of Pipeline™ Embolization Device in small (<2.5mm) cerebral vessels for aneurysm treatment: single institution experience
    Puri, Ajit S.
    Massari, Francesco
    Asai, Takumi
    Marosfoi, Miklos
    Kan, Peter
    Hou, Samuel Y.
    Howk, Mary
    Perras, Mary
    Brooks, Christopher
    Clarencon, Frederic
    Gounis, Matthew J.
    Wakhloo, Ajay K.
    NEURORADIOLOGY, 2016, 58 (03) : 267 - 275
  • [43] Last-Recorded P2Y12 Reaction Units Value Is Strongly Associated with Thromboembolic and Hemorrhagic Complications Occurring Up to 6 Months after Treatment in Patients with Cerebral Aneurysms Treated with the Pipeline Embolization Device
    Almandoz, J. E. Delgado
    Crandall, B. M.
    Scholz, J. M.
    Fease, J. L.
    Anderson, R. E.
    Kadkhodayan, Y.
    Tubman, D. E.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2014, 35 (01) : 128 - 135